Godavari Biorefineries Limited — PPTs, 19-11-2024: Investor Presentation

**Financial Highlights:**

For H1FY25, Godavari Biorefineries Limited reported a revenue from operations of ₹8,435 crore, reflecting a 25% year-over-year increase. The revenue mix revealed that domestic sales constituted 88% of total revenue. The company experienced significant growth in sales volume across sugar and bio-based chemicals, showing increases of 102% and 18%, respectively. However, the ethanol segment saw a 29% decline in volume due to government restrictions on production from sugarcane juice.

**Strategic Initiatives and Growth Drivers:**

The company is focused on expanding its bio-based chemicals segment, capitalizing on the rising demand for sustainable solutions. The lifting of government restrictions on ethanol production is expected to bolster market traction moving forward. GBL aims to utilize proceeds from its recent IPO for debt repayment and reinvestment into high-return projects, particularly in bio-based chemicals.

**Business Developments:**

GBL recently expanded its manufacturing capabilities, allowing for optionality between sugar and ethanol production. This strategic flexibility is crucial in adapting to market demands and improving supply chain efficiency.

**Market Position and Competitive Advantage:**

GBL is one of India's largest ethanol producers and is distinguished by its integrated biorefinery model, which includes a diverse portfolio of bio-based products. The company's robust relationships with farmers and its well-established position in the market enhance its competitive edge.

**Investor Implications:**

With a favorable outlook for growth driven by government policies and increased demand for bio-based products, GBL presents potential upside for investors. The planned expansions and rejuvenated ethanol production capabilities suggest strong future earnings potential. Watch closely for developments in the upcoming quarters as the company navigates market changes.